Key result
A 57-year-old female with cardiac hypereosinophilia developed recurrent mechanical mitral valve thrombosis despite being on coumadin with a supratherapeutic INR, highlighting the potential inadequacy of standard anticoagulation in this population.
Why the study?
Hypereosinophilia can cause multiorgan damage and cardiac thrombus, but questions remain regarding optimal anticoagulation and management during atypical presentations.
Case Report (n=1)
No
Cardiac hypereosinophilia can lead to recurrent mechanical valve thrombosis even in the setting of supratherapeutic INR on coumadin, suggesting alternative anticoagulation strategies may be needed.
Answers are grounded in this paper and cite their sources.
May signal anticoagulation failure risk in cardiac hypereosinophilia; leaves open optimal regimens for mechanical valves.
Hypereosinophilia (HES) is a rare, but highly fatal, disease that results in excess eosinophils causing multiorgan damage, mainly manifesting as extensive inflammation contributing to fibrosis. Notably, cardiac involvement occurs in almost half the cases and can often lead to thrombus development. This is a unique case of HES contributing to recurrent cardiac thrombus formation on a mechanical mitral valve in the setting of a patient who had a supratherapeutic international normalized ratio (INR) while on coumadin. The rarity of this case is also displayed in the patient's negativity for one of the fusion genes that are highly suggestive of cardiac HES, the demographics of her female gender, and her first objective sign being T-wave inversions versus the usual heart failure signs and symptoms. This case raises awareness of the disorder but also the importance of keeping its potential exacerbations on the differential, even in the setting of atypical presentations. With this, it also begs the question of whether coumadin is the proper anticoagulant of choice in these patients and whether other parameters should be considered.
No takes yet. Share an insight, caveat, or question.
Ostojić et al. (2022) conducted a case report in Cardiac hypereosinophilia with recurrent mechanical valve thrombosis (n=1). Coumadin was evaluated. A 57-year-old female with cardiac hypereosinophilia developed recurrent mechanical mitral valve thrombosis despite being on coumadin with a supratherapeutic INR, highlighting the potential inadequacy of standard anticoagulation in this population.
Synapse has enriched 10 related papers. Consider them for comparative context: